February 13, 2020 / 12:56 PM / 6 days ago

BRIEF-First Patient Dosed In Pivotal Phase 3 Trial Of SNF472 In Calciphylaxis

Feb 13 (Reuters) -

* FIRST PATIENT DOSED IN PIVOTAL PHASE 3 TRIAL OF SNF472 IN CALCIPHYLAXIS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below